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Comments and Responses 
Screening for Vitamin D Deficiency 
 
TO THE EDITOR: The U.S. Preventive Services Task Force has concluded that the current 
evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D 
deficiency in asymptomatic adults. As LeBlanc and colleagues' review (1) shows, this current 
evidence comprises studies whereby supplementation (variable doses of vitamin D2 or D3 with or 
without calcium) has been monitored mainly by measuring total concentrations of 25-(OH)D. 
Instead, future studies should focus on assessing concentrations of bioavailable vitamin D.  
 
Concentrations of total 25-(OH)D and 1,25-dihydroxyvitamin D measured routinely in daily 
practice are known to differ from those of bioavailable vitamin D. Free and bioavailable vitamin 
D concentrations depend on the vitamin D±binding protein and ethnicity (2). In addition, we 
need evidence of techniques to increase concentrations of bioavailable vitamin D, such as 
obtaining more outdoor physical activity, which might increase biosynthesis and bioavailable 
concentrations of vitamin D3 and circumvent hypervitaminosis D (3). Harmful effects of 
hypervitaminosis D might be due solely to excess biosynthesized sequestrated vitamin D as a 
result of inappropriate oral supplementations and of not being converted to active bioavailable 
vitamin D. Excess vitamin D is arteriotoxic and causes elastocalcinosis, which induces 
destruction of elastic fibers, which leads to arterial stiffness and causes arterial calcification 
through upregulation of 1,25-dihydroxyvitamin D3 receptors and increased calcium uptake in 
smooth-muscle cells of the arteries (4) (5).  
 
Research resources are finite in these times of austerity; hence, they should be allocated 
appropriately. Robust and pertinent evidence is needed to formulate educational and 
interventional policies that can be implemented to prevent the global public health problem of 
cardiometabolic diseases and autoimmune and neoplastic conditions associated with decreased 
bioavailable concentrations of vitamin D.  
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